After follow-up, throughout the vaccine schedule, both participants naïve to COVID-19 and participants with previous SARS-CoV-2 infection showed an increase in CD4+ T-lymphocytes following the first and second vaccine doses and maintained the percentage of this cell population, in contrast to that reported in infected participants who showed a decrease in this cell population [25]. Here, CD4 is linked to COVID-19.